Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention
Catheterization and Cardiovascular Interventions · 2026-11 · 108 (6) · 2185-2192
DOI: 10.1002/ccd.70905 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 21.09.2026. Verfasst von Marc Meller Bröchner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Coronary Artery Disease, Coronary Stenosis, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The prognostic benefit of revascularization for unprotected left main (LM) disease remains uncertain, as guideline endorsement of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) precludes comparison with deferral, which is unlikely to be assessed in a randomized trial.
Objectives
This study aimed to evaluate the prognostic impact of revascularization (PCI/CABG) versus deferred treatment of isolated, unprotected LM disease using real‐world data.
Methods
Patients with isolated, unprotected LM disease identified by invasive coronary angiography on the indication chronic coronary syndrome between January 2002 and January 2021, registered in the Western Denmark Heart Registry, were identified and split into four groups: Defer ≤ 50% stenosis, defer > 50% stenosis, PCI, or CABG. Acute coronary syndrome (ACS), revascularization, stroke, and all‐cause mortality risks within 5 years were assessed. Adjusted analyses were conducted.
Results
Of 4848 patients identified, 2819 patients underwent PCI, 467 CABG, 992 were in the defer ≤ 50% group, and 570 in defer > 50%. The 5‐year survival probability was 89.5% for PCI, 94.1% for CABG, 91.7% for defer ≤ 50%, and 84.0% for defer > 50% ( p < 0.0005%). Cumulative incidence of ACS was 7.9% for PCI, 3.0% for CABG, 5.3% for defer ≤ 50%, and 8.2% for defer > 50% ( p < 0.0005). For revascularization, numbers were 10.2%, 7.0%, 7.6%, and 15.4% ( p < 0.0005) and stroke 3.6%, 2.1%, 2.5%, and 3.8% ( p < 0.005). In adjusted analyses, the results were unchanged.
Conclusions
Using real‐world data, this study demonstrated that either PCI or CABG was associated with improved survival in patients with LM disease, when diameter stenosis exceeded 50%. PCI was associated with higher rates of non‐fatal ACS and repeat revascularization compared to CABG but similar rates as deferred treatment. Clinical Perspectives The prognostic benefit of revascularization for isolated and unprotected left main disease remains uncertain, as guideline endorsement of PCI or CABG precludes comparison with deferral. Deferred revascularization of unprotected LM disease with >50% diameter stenosis in patients with chronic coronary syndrome was associated with increased all‐cause mortality and non‐fatal acute coronary syndrome. Revascularization remains the treatment of choice in patients with significant unprotected LM disease for prognostic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Cardiology, Odense University Hospital, Odense, Denmark.
- Department of Cardiothoracic Surgery, Aalborg University Hospital, Aalborg, Denmark.
- Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Marc Meller Bröchner, Evald Høj Christiansen, Kristian Kragholm, Gennady Atroshchenko, Leif Thuesen, Ashkan Eftekhari
Zitieren
APA
Bröchner, M. M., Christiansen, E. H., Kragholm, K., Jensen, L. O., Atroshchenko, G., Modrau, I. S., Riber, L., Pedersen, O. B., Thuesen, L., Torp-Pedersen, C., & Eftekhari, A. (2026). Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions, 108(6), 2185-2192. https://doi.org/10.1002/ccd.70905
Vancouver
Bröchner MM, Christiansen EH, Kragholm K, Jensen LO, Atroshchenko G, Modrau IS, et al. Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 2026;108(6):2185-2192. doi:10.1002/ccd.70905
BibTeX
@article{Brchner2026,
author = {Bröchner, Marc Meller and Christiansen, Evald Høj and Kragholm, Kristian and Jensen, Lisette Okkels and Atroshchenko, Gennady and Modrau, Ivy Susanne and Riber, Lars and Pedersen, Oliver Buchhave and Thuesen, Leif and Torp-Pedersen, Christian and Eftekhari, Ashkan},
title = {Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {6},
pages = {2185--2192},
doi = {10.1002/ccd.70905}
}
EUVIMED